GLPBio

Coagulation & Hemostasis

Products Related to Coagulation & Hemostasis(124)

  • GA20982 structure
    GA20982Boc-D-Phe-Pro-OH
    CAS: 38675-10-4
    Purity: >98%

    A synthetic intermediate

  • GC17816 structure
    GC17816I-BOP
    CAS: 128719-90-4
    Purity: >95.00%

    TP specific agonist

  • GC18219 structure
    GC182196-hydroxy Warfarin
    CAS: 17834-02-5
    Purity: >98.00%

    6-hydroxy Warfarin is a metabolite of (+)-warfarin , which is a weaker vitamin K antagonist than (-)-warfarin .

  • GC18323 structure
    GC18323Picotamide
    CAS: 32828-81-2
    Purity: >98.00%

    Picotamide est un inhibiteur de l'agrégation plaquettaire avec une valeur d' IC 50 de 0.76μM.

  • GC18637 structure
    GC1863711β-Prostaglandin F2α
    CAS: 38432-87-0
    Purity: >98.00%

    11β-Prostaglandin F2α (11β-PGF2α) is the primary plasma metabolite of PGD2 in vivo.

  • GC18707 structure
    GC18707Pimprinine
    CAS: 13640-26-1
    Purity: >98%

    Pimprinine is an alkaloid originally isolated from Streptomyces that has diverse biological activities, including anticonvulsant, antiplatelet, and antimicrobial properties.

  • GC18768 structure
    GC18768Prostaglandin E1 ethyl ester
    CAS: 35900-16-4
    Purity: >98%

    Prostaglandin E1 (PGE1) is the theoretical cyclooxygenase metabolite of dihomo-γ-linolenic acid.

  • GC18837 structure
    GC18837Carbocyclic Thromboxane A2
    CAS: 74034-56-3
    Purity: >98%

    CTA2 is a stable analog of TXA2.

  • GC18999 structure
    GC18999Prostaglandin D1
    CAS: 17968-82-0
    Purity: >98.00%

    Prostaglandin D1 (PGD1) is the theoretical D-series metabolite of DGLA, but to date it has not been isolated as a natural product.

  • GC20095 structure
    GC200955,7-Dihydroxy-4-methylcoumarin
    CAS: 2107-76-8
    Purity: >98%

    5,7-Dihydroxy-4-methylcoumarin is a coumarin derivative from Mexican tarragon. 5,7-Dihydroxy-4-methylcoumarin possesses antifungal and antibacterial activities .

  • GC40157 structure
    GC40157PAR4 (1-6) amide (mouse) (trifluoroacetate salt)
    Purity: >95.00%

    PAR4 (1-6) amide is a synthetic peptide agonist of proteinase-activated receptor 4 (PAR4) and an amide form of PAR4 (1-6) that corresponds to residues 1-6 of the amino terminal tethered ligand sequence of mouse PAR4 and residues 60-65 of the full-length sequence.

  • GC40159 structure
    GC40159PAR1 (1-6) (mouse, rat) (trifluoroacetate salt)
    Purity: >95.00%

    PAR1 (1-6) is a hexapeptide that corresponds to amino acid residues 1-6 of the amino terminal tethered ligand sequence of mouse and rat proteinase-activated receptor 1 (PAR1), residues 42-47 of the full-length mouse sequence, and residues 46-51 of the full-length rat sequence.

  • GC40336 structure
    GC403365-cis Carbaprostacyclin
    CAS: 69609-77-4
    Purity: >99.00%

    5-cis Carbaprostacyclin is a stable analog of PGI2 and an isomer of carbaprostacyclin.

  • GC40529 structure
    GC405297-hydroxy Warfarin
    CAS: 17834-03-6
    Purity: >98%

    7-hydroxy Warfarin is a metabolite of (-)-warfarin, which is a more potent vitamin K antagonist than (+)-warfarin.

  • GC40552 structure
    GC40552(R)-Acenocoumarol
    CAS: 66556-77-2
    Purity: >98.00%

    Acenocoumarol is a short-lived oral anti-coagulant, which, like warfarin, functions by inhibiting vitamin K epoxide reductase.

  • GC40553 structure
    GC40553(S)-Acenocoumarol
    CAS: 66556-78-3
    Purity: >98.00%

    Acenocoumarol is a short-lived oral anti-coagulant, which, like warfarin, functions by inhibiting vitamin K epoxide reductase.

  • GC40585 structure
    GC405856α-Prostaglandin I1
    CAS: 62777-90-6
    Purity: >99.00%

    6α-Prostaglandin I1 (6α-PGI1) is a stable Prostaglandin I2 (PGI2) analog resistant to hydrolysis in aqueous solutions.

  • GC40586 structure
    GC405866β-Prostaglandin I1
    CAS: 62770-50-7
    Purity: >99.00%

    6β-PGI1 is a stable PGI2 analog resistant to hydrolysis in aqueous solutions.

  • GC40590 structure
    GC40590ent-8-iso-15(S)-Prostaglandin F2α
    CAS: 214748-66-0
    Purity: >98.00%

    Isoprostanes are produced by the non-enzymatic, free radical peroxidation of phospholipid-esterified arachidonic acid.

  • GC40610 structure
    GC40610Prostaglandin D3
    CAS: 71902-47-1
    Purity: >98.00%

    Prostaglandin D3 (PGD3) is produced by the metabolism of EPA via the COX pathway.

  • GC40740 structure
    GC40740WHI-P258
    CAS: 21561-09-1
    Purity: >98.00%

    WHI-P258 is a quinazoline compound that modeling studies suggested would bind to the active site of JAK3 with an estimated Ki value of 72 μM.

  • GC40745 structure
    GC4074513,14-dehydro-15-cyclohexyl Carbaprostacyclin
    CAS: 145375-81-1
    Purity: >98.00%

    13,14-dehydro-15-cyclohexyl Carbaprostacyclin is a chemically stable analog of PGI2.

  • GC40973 structure
    GC4097316(R)-Iloprost
    CAS: 74843-13-3
    Purity: >98.00%

    Iloprost is a second generation structural analog of prostacyclin (PGI2) with about ten-fold greater potency than the first generation stable analogs, typified by carbaprostacyclin.

  • GC40974 structure
    GC4097416(S)-Iloprost
    CAS: 74843-14-4
    Purity: >98%

    Iloprost is a second generation structural analog of prostacyclin (PGI2) with about ten-fold greater potency than the first generation stable analogs, typified by carbaprostacyclin.